Genetic variation in the renin-angiotensin system, use of renin-angiotensin system inhibitors and the risk of myocardial infarction

Anke-Hilse Maitland-van der Zee, Diane B. M. A. van Wieren-de Wijer, Anthonius de Boer, Abraham A. Kroon, Peter W. de Leeuw, Paul Schiffers, Rob G. J. H. Janssen, Bruce M. Psaty, Cornelia M. V. Duijn, Bruno H. Ch Stricker, Olaf H. Klungel*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Web of Science)
Original languageEnglish
Pages (from-to)208-214
JournalJournal of the Renin-angiotensin-aldosterone System
Issue number3
Publication statusPublished - Sep 2011


  • ACE inhibitors
  • ACE polymorphism
  • angiotensin II type 1 receptor antagonists
  • angiotensin II type 1 receptor polymorphism
  • angiotensinogen polymorphism
  • myocardial infarction
  • pharmacogenetics

Cite this